These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The metabotropic glutamate receptors: potential drug targets for the treatment of anxiety disorders? Pitsikas N Eur J Pharmacol; 2014 Jan; 723():181-4. PubMed ID: 24361306 [TBL] [Abstract][Full Text] [Related]
6. Gender specific influence of endogenous glutamate release on stress-induced fear in rats. Jain SK; Zelena D Endocr Regul; 2011 Jan; 45(1):13-21. PubMed ID: 21314206 [TBL] [Abstract][Full Text] [Related]
7. Neurobiology of anxiety disorders and implications for treatment. Garakani A; Mathew SJ; Charney DS Mt Sinai J Med; 2006 Nov; 73(7):941-9. PubMed ID: 17195879 [TBL] [Abstract][Full Text] [Related]
8. The effects of midazolam and D-cycloserine on the release of glutamate and GABA in the basolateral amygdala of low and high anxiety rats during extinction trial of a conditioned fear test. Lehner M; Wisłowska-Stanek A; Taracha E; Maciejak P; Szyndler J; Skórzewska A; Turzyńska D; Sobolewska A; Hamed A; Bidziński A; Płaźnik A Neurobiol Learn Mem; 2010 Nov; 94(4):468-80. PubMed ID: 20807585 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of generalized anxiety: new pharmacologic approaches]. Boulenger JP Encephale; 1995; 21(6):459-66. PubMed ID: 8674471 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide]. Satow A; Maehara S; Ise S; Hikichi H; Fukushima M; Suzuki G; Kimura T; Tanak T; Ito S; Kawamoto H; Ohta H J Pharmacol Exp Ther; 2008 Aug; 326(2):577-86. PubMed ID: 18487514 [TBL] [Abstract][Full Text] [Related]
11. Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Swanson CJ; Bures M; Johnson MP; Linden AM; Monn JA; Schoepp DD Nat Rev Drug Discov; 2005 Feb; 4(2):131-44. PubMed ID: 15665858 [TBL] [Abstract][Full Text] [Related]
12. Glutamate as a therapeutic target in psychiatric disorders. Javitt DC Mol Psychiatry; 2004 Nov; 9(11):984-97, 979. PubMed ID: 15278097 [TBL] [Abstract][Full Text] [Related]
14. Role of metabotropic glutamate receptors in the control of neuroendocrine function. Durand D; Pampillo M; Caruso C; Lasaga M Neuropharmacology; 2008 Sep; 55(4):577-83. PubMed ID: 18616955 [TBL] [Abstract][Full Text] [Related]
15. N-antipyrine-3, 4-dichloromaleimide, an effective cyclic imide for the treatment of chronic pain: the role of the glutamatergic system. Quintão NL; da Silva GF; Antonialli CS; de Campos-Buzzi F; Corrêa R; Filho VC Anesth Analg; 2010 Mar; 110(3):942-50. PubMed ID: 20185671 [TBL] [Abstract][Full Text] [Related]
16. Anxiety levels and related pharmacological drug treatment: a memorandum for the third millennium. Pasquini M; Berardelli I Ann Ist Super Sanita; 2009; 45(2):193-204. PubMed ID: 19636172 [TBL] [Abstract][Full Text] [Related]
18. Neurotoxicity of polyamines and pharmacological neuroprotection in cultures of rat cerebellar granule cells. Sparapani M; Dall'Olio R; Gandolfi O; Ciani E; Contestabile A Exp Neurol; 1997 Nov; 148(1):157-66. PubMed ID: 9398458 [TBL] [Abstract][Full Text] [Related]
19. Contribution of spinal glutamatergic receptors to the antinociception caused by agmatine in mice. Gadotti VM; Tibola D; Paszcuk AF; Rodrigues AL; Calixto JB; Santos AR Brain Res; 2006 Jun; 1093(1):116-22. PubMed ID: 16765330 [TBL] [Abstract][Full Text] [Related]
20. Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs. Wierońska JM; Pilc A Neurochem Int; 2009; 55(1-3):85-97. PubMed ID: 19428811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]